Early research (Phase 1)Ended earlyNCT04526509
What this trial is testing
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors
Who this might be right for
Neoplasms
Adaptimmune 12